Cynthia F. Norris, MD
Areas of expertise: Sickle cell disease
Locations: Main Building, Buerger Center for Advanced Pediatric Care
About Cynthia F. Norris, MD
Dr. Norris is currently serving as the Interim Co-Director of the Sickle Cell Program and sees patients in Hematology Clinic. She finds joy in direct patient care and feels strongly about the team approach to patient care involving parents and other family members, nursing, social work, psychology and other appropriate disciplines. She completed a residency in the Pediatric Integrative Medicine Program through the University of Arizona and strives to treat all aspects of her patients' condition. She completed the Physician Well-being Director Course at Stanford and currently serves as the Division of Hematology Well-Being Champion. She is actively involved in quality improvement initiatives for the program.
Titles
Attending Physician
Interim Co-Director of the Sickle Cell Program
Division of Hematology Wellbeing Champion
Certifications
Pediatric Hematology-Oncology – American Board of Pediatrics
Awards and Honors
2008, Physician Partnering Award, Children’s Hospital of Philadelphia
Leadership and Memberships
2025-present, American Society of Hematology
2018-present Medical Advisory Board, 2015-2021 Board member - Make-A-Wish, Philadelphia, Delaware, Susquehanna Valley Chapter
2021-present Medical Advisor, Crescent Foundation – A Sickle Cell Initiative
Education & training
Medical Degree
University of Medicine and Dentistry of New Jersey, Newark, NJ
Residency
Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pa.
Fellowship
Pediatric Hematology/Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
Publications
Publications
2025
Jalloul, M., Hutchinson, M., Norris, C., Kozak, B., Kaplan S. A coaching model for sonographers: enhancing skill competency in transcranial Doppler examinations. Pediatr Radiol (2025).
2024
Rao N, McKnight T, Norris C, Scoles D. Salmon Patch Maculopathy: An Amblyogenic Complication of Pediatric Sickle Cell Retinopathy. Am J Ophthalmol Case Rep 2024, 36: 102203.
2023
Kanter J, Brown RC, Norris C, Nair SM, Kutlar A, Manwani D, Shah N, Tanaka C, Bodla S, Sanchez-Olle G, Albers U, Liles D. Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease. Blood Adv 2023, 7 (6): 943-952.
Abstracts (includes Posters and Scientific Presentations)
2025
Norris C, Pumiglia E, Brugger R, Randall J, Brandemarte A, Maloney B, Scoles D. Improving Ophthalmologic Screening in Pediatric and Young Adult Patients Living with Sickle Cell Disease. Poster presentation at 20th Annual Sickle Cell & Thalassaemia Conference, October 2025.
Hartman-Hall H, Marchalik D, Fahey L, Boldizar L, Bamat T, Petrini L, Stewart M. Increasing Preventive Health Care Utilization Among Clinicians and Trainees. Oral presentation at 2025 American Conference on Physician Health, September 2025.
Norris C, Devine K, Witmer C, Brandemarte A, Williams L, Bythrow M. Improving Naloxone Co-Prescription Rates in Patients Living with Sickle Cell Disease (SCD) Who Are Receiving an Outpatient (OP) Opioid Prescription. Poster presentation at Sickle Cell Disease: Existing Paradigms and Novel Approaches conference, New York Academy of Sciences, April 2025.
2024
Norris C, Foppert L, Brooks E, Brandemarte A, Brugger R, Sabrick J, Knox K, Kaspin A, Robinson S, McKnight T, Pumiglia E, Scoles D, Maloney B, Thompson A; Clinical Management Bundle for Patients with Sickle Cell Disease: Improving Completion of Age-Specific Screening Tests and Disease-Modifying Therapy Use. Blood 2024; 144 (Supplement 1): 519. (Oral presentation at the annual meeting of the American Society of Hematology, December 2024).
Thompson A, Umana J, Sabrick J, McKnight T, Williams L, Rana K, Baar W, Coogle L, Mecado O, Witmer C, Ellison A, Norris C. Innovative Model for Creation and Use of Co-Developed Pain Management Plans for Patients with Sickle Cell Disease. Blood 2024; 144 (Supplement 1): 603.
Norris C, Fahey L, Boldizar L. Increasing Preventative Health Care Among Physicians Through Peer Support and Accountability (Poster presentation at CHOP Employee Well Being Summit, November 2024).
Smith-Whitley K, Brooks E, Brandemarte A, Norris C. Sickle Cell Disease
Electronic Health Record Population Management Approach for Delivery of High-Quality Care: Supporting Efforts to Track Sickle Cell and red Cell Antigen Genotype (Oral presentation at the annual meeting of the American Society of Hematology/Oncology, April 2024).
2023
Smith-Whitley K, Brooks E, Brandemarte, A, Norris C. Sickle Cell Disease Electronic Health Record Population Management Approach to Support Delivery of High-Quality Care: Leaving Paper Lists Behind. (Oral presentation at the annual meeting of the American Society of Hematology, December 2023).
Fuh B, Inati A, Inusa B, Abboud M, Norris C, Kalpatthi R, Telfer P, Trompeter S, Dixon S, Enriquez A, Akhlaghi F, Smith-Whitley K, Brown C. Interim Safety and Efficacy of Voxelotor in Children Aged 2 to <4 Years With Sickle Cell Disease (Poster presentation at the American Society of Pediatric Hematology/Oncology (ASPHO) May 2023).
2021
Norris C, Smith-Whitley, K. Management of COVID-19 Infections in Children and Young Adults with Sickle Cell Disease. (Oral presentation at the Annual Meeting of the National Sickle Cell Disease Conference, October 2021).
Norris C, Smith-Whitley, K. COVID-19 Vaccination Side Effects in Children and Adults with Sickle Cell Disease: A Single Center Experience. (Oral presentation at the Annual Meeting of the National Sickle Cell Disease Conference, October 2021).